Abiopharma

🔍 Kochendoerfer Gerd (Executive)

Company: AtaiBeckley Inc. (ATAI)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 50,000 shares of Common Stock at $1.6 per share (Direct)
  Date: 2026-06-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 50,000.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 50,000 shares of Common Stock at $5.0 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2
• Sold 50,000 shares of Stock Option at $1.6 per share (Derivative)
  Date: 2026-06-26 | Code: M | Expires: 2035-01-01 | equity_swap_involved: 0 | shares_owned_after: 1,400,000.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2026.
• F2: The stock option vested (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying the option on December 3, 2025 and as to the remaining 75% of the total number of shares in 36 substantially equal monthly installments thereafter.